Document Detail

The actions of prostaglandins and their interactions with angiotensin II in the isolated perfused human placental cotyledon.
MedLine Citation:
PMID:  3518789     Owner:  NLM     Status:  MEDLINE    
The prostaglandins PGE1, PGE2, PGD2, PGF2 alpha, U46619 and 6 beta-PGI1 were administered as bolus injections both separately and in combination with angiotensin II into the fetal circulation of isolated human placental cotyledons perfused in vitro. PGF2 alpha and PGD2 caused small dose-dependent increases in fetal perfusion pressure when compared with U46619 which acted as an extremely potent vasoconstrictor of the fetal-placental vasculature. PGE1 caused very small dose-dependent decreases in fetal perfusion pressure when injected on its own. In combination with angiotensin II, PGE1, PGD2 and 6 beta-PGI1 caused significant, dose-related attenuations of the angiotensin II vasoconstrictive response whereas PGE2, PGF2 alpha and U46619 potentiated the response. Injections of angiotensin II after the infusion of indomethacin into the fetal circulation resulted in a potentiation of angiotensin II induced vasoconstriction. The results indicate that prostaglandins exert their effects on the fetal-placental circulation by modulating the actions of angiotensin II.
D G Glance; M G Elder; L Myatt
Related Documents :
3496789 - The role of dialysate in the stimulation of interleukin-1 production during clinical he...
7730359 - Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin f2 alpha.
8667229 - Platelet-activating factor production in stimulated macrophages is down-regulated by co...
8217499 - Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage.
6605929 - Induction of interleukin 1 secretion by adjuvant-active peptidoglycans.
2580319 - Comparative studies of prostaglandin e2, phenylisopropyladenosine, clonidine and propra...
17576779 - A lad-iii syndrome is associated with defective expression of the rap-1 activator calda...
10072549 - Endogenous platelet-activating factor is critically involved in effector functions of e...
22677379 - Identification of different proaggregatory abilities of activated platelet subpopulations.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of obstetrics and gynaecology     Volume:  93     ISSN:  0306-5456     ISO Abbreviation:  Br J Obstet Gynaecol     Publication Date:  1986 May 
Date Detail:
Created Date:  1986-07-15     Completed Date:  1986-07-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7503752     Medline TA:  Br J Obstet Gynaecol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  488-94     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Alprostadil / pharmacology
Angiotensin II / pharmacology*
Drug Interactions
Epoprostenol / pharmacology
Placenta / blood supply,  drug effects*
Prostaglandin D2
Prostaglandin Endoperoxides, Synthetic / pharmacology
Prostaglandins / pharmacology*
Prostaglandins D / pharmacology
Prostaglandins E / pharmacology
Prostaglandins, Synthetic / pharmacology
Reg. No./Substance:
0/Prostaglandin Endoperoxides, Synthetic; 0/Prostaglandins; 0/Prostaglandins D; 0/Prostaglandins E; 0/Prostaglandins, Synthetic; 11128-99-7/Angiotensin II; 35121-78-9/Epoprostenol; 363-24-6/Dinoprostone; 41598-07-6/Prostaglandin D2; 62770-50-7/5,6-dihydroprostacyclin; 745-65-3/Alprostadil; 76898-47-0/15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Doppler ultrasound assessment of cerebral blood flow in the human fetus.
Next Document:  Ligand interactions at the active site of aspartate transcarbamoylase from Escherichia coli.